Onward Medical N.V. Logo

Onward Medical N.V.

Develops spinal stimulation therapies to restore movement for people with spinal cord injury.

ONWD | AS

Overview

Corporate Details

ISIN(s):
NL0015000HT4
LEI:
9845007A2CC4C8BFSB80
Country:
Netherlands
Address:
Schimmelt 2, 5611ZX Eindhoven
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Onward Medical N.V. is a medical technology company developing therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's core technology is ARC Therapy, a platform that uses targeted, programmed electrical stimulation of the spinal cord. Its portfolio includes the ARCEX System, a non-invasive, external device cleared by the FDA for use in the United States to improve hand and arm function in individuals with SCI. Onward is also advancing investigational implantable systems, including ARCIM and ARCBCI, which may be combined with a brain-computer interface (BCI). The company's research and development is supported by multiple FDA Breakthrough Device Designations and a portfolio of nearly 400 issued or pending patents.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Onward Medical N.V. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-18 07:30
Regulatory News Service
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blo…
English 205.3 KB
2025-09-02 07:42
Interim Report
ONWARD Medical N.V., Halfjaarlijkse financiële verslaggeving
English 8.8 MB
2025-09-02 07:30
Interim Report
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the Fi…
English 208.1 KB
2025-08-18 18:30
Regulatory News Service
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Stu…
English 208.3 KB
2025-07-07 11:20
Regulatory News Service
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison…
English 154.2 KB
2025-06-12 07:52
Post-Annual General Meeting Information
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
English 138.1 KB
2025-06-11 19:00
Post-Annual General Meeting Information
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
English 138.1 KB
2025-05-01 06:28
Pre-Annual General Meeting Information
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders a…
English 115.4 KB
2025-04-30 17:30
Pre-Annual General Meeting Information
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders a…
English 115.4 KB
2025-04-28 08:30
Report Publication Announcement
ONWARD Medical Announces Release of 2024 Annual Report
English 104.0 KB
2025-04-28 08:09
Annual Report (ESEF)
ONWARD Medical N.V., Jaarlijkse financiële verslaggeving
English 8.0 MB
2025-04-01 07:30
Earnings Release
ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice…
French 291.0 KB
2024-12-20 07:51
Regulatory News Service
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization …
English 128.5 KB
2024-12-19 18:00
Regulatory News Service
ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de…
French 155.3 KB
2024-10-29 07:28
Share Issue/Capital Change
ONWARD® Medical Publishes Closing of Bookbuild Offering
English 89.0 KB

Automate Your Workflow. Get a real-time feed of all Onward Medical N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Onward Medical N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-01-19 G.R. Courtine Non-Executive member Other 451,822 N/A
2023-01-03 D.L. Marver Non-Executive member Other 385,000 N/A
2022-12-23 F.A. Colen Non-Executive member Other 47,740 N/A
2022-11-18 D.L. Marver Non-Executive member Other 954,814 N/A
2022-09-29 V.E. Riefberg Non-Executive member Other 16,000 N/A
2021-12-15 J.K. Ohrstrom Non-Executive member Other 38,000 N/A
2021-10-22 D.L. Marver Non-Executive member Other 6,765 N/A

Peer Companies

Company Country Ticker View
3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan 7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France AFME
Airway Medix S.A. Logo
Develops single-use devices for mechanically ventilated patients in ICUs and anesthesiology.
Poland AWM
Alcon AG Logo
Global leader in eye care, offering surgical equipment, contact lenses, and ocular health products.
Switzerland ALC
Allmed Solutions Ltd. Logo
Develops, manufactures, and markets minimally invasive medical devices and solutions globally.
Israel ALMD
Alteco Medical AB Logo
Develops blood purification devices to treat sepsis and septic shock in ICUs.
Sweden ALTE
Ambu Logo
Develops single-use devices for endoscopy, anesthesia, and patient monitoring to improve safety.
Denmark AMBU

Talk to a Data Expert

Have a question? We'll get back to you promptly.